Ocular surface reconstruction using collagen matrix implant in cases of moderate to severe symblepharon: A pilot study

Key Points

• Evaluate the safety and efficacy of collagen matrix implants for reconstructing the ocular surface in symblepharon cases.
• Pilot study design focused on moderate to severe symblepharon cases.
• Utilized collagen matrix implant as an adjunct treatment for ocular surface reconstruction.
• Followed anatomical outcomes for 6 months post-implantation.
• Demonstrated safe application of collagen matrix implants with no recurrences at 6 months.
• Showed encouraging short-term anatomical outcomes in the treated cases.